ArticleBlood advances2020

Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results.

Claude Gardin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.